Determinants of self‐monitoring of blood glucose in patients with Type 1 diabetes: a multi‐centre study in Brazil

Gomes, Marı́lia B.; Tannus, Lucianne Righeti Monteiro; Cobas, Roberta Arnoldi; Matheus, Alessandra Saldanha de Mattos; Dualib, Patricia; Zucatti, Alessandra Teixeira Netto; Cani, Catarina Gomes; Guedes, Alexis Dourado; Santos, Flávia Marques; Sepúlveda, Janice; Tolentino, Monica; Façanha, Mônica Cardoso; Faria, Ana Cristina R. A.; Lavigne, Suzana; Montenegro, Ana Paula Dias Rangel; Rodacki, Melanie; Guedes, Maria de Fátima S; Szundy, R; Cordeiro, Marilena M; Santos, P T S; Negrato, Carlos Antônio

doi:10.1111/dme.12236

Cited by 17 publications

(15 citation statements)

References 26 publications

(73 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Insulin represented 26.1% of expenses. Further analysis of the Cobas study also showed that more frequent SMBG (up to four tests per day) was associated with improved HbA 1c levels [25].…”

Section: Expensive Blood Glucose Monitoringmentioning

confidence: 88%

Financial costs for families of children with Type 1 diabetes in lower‐income countries

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Insulin represented 26.1% of expenses. Further analysis of the Cobas study also showed that more frequent SMBG (up to four tests per day) was associated with improved HbA 1c levels [25].…”

Section: Expensive Blood Glucose Monitoringmentioning

confidence: 88%

Financial costs for families of children with Type 1 diabetes in lower‐income countries

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Furthermore, individual health behaviour may influence various healthcare outcomes . Persons with Type 1 diabetes and higher socio‐economic status, for example, measure their blood glucose more often than those of lower socio‐economic status . Thus, inequalities in short‐term healthcare outcomes cannot be explained by one underlying factor, but are very likely caused through a multifactorial process.…”

Section: Discussionmentioning

confidence: 99%

Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio‐economic status and area‐level deprivation in Type 1 diabetes mellitus: a systematic review

2017

View full text Add to dashboard Cite

Aim The aim of this systematic review was to examine the associations of individual-level as well as area-level socioeconomic status and area-level deprivation with glycaemic control, hypoglycaemia and diabetic ketoacidosis in people with Type 1 diabetes mellitus.Methods Ovid MEDLINE was searched to identify relevant cohort, case-control or cross-sectional studies published between January 2000 and June 2015. Search results were screened by title, abstract and keywords to identify eligible publications. Decisions on inclusion or exclusion of full texts were made independently by two reviewers. The Newcastle-Ottawa Scale was used to estimate the methodological quality of included studies. Quality assessment and extracted data of included studies were synthesized narratively and reported according to the PRISMA statement.Results Literature search in Ovid MEDLINE identified 1345 eligible studies. Twenty studies matched our inclusion and exclusion criteria. Two articles were additionally identified through hand search. According to the Newcastle-Ottawa Scale, most of the studies were of average quality. Results on associations of socio-economic status and area-level deprivation with glycaemic control and hypoglycaemia were contradictory between studies. By contrast, lower socioeconomic status and higher area-level deprivation were associated with a higher risk for diabetic ketoacidosis in all except one study.Conclusions Lower socio-economic status and higher area-level deprivation are associated with a higher risk of experiencing diabetic ketoacidosis in people with Type 1 diabetes mellitus. Access to care for socially deprived people needs to be expanded to overcome impairing effects on the course of the condition and to reduce healthcare disparities.

show abstract

“…The data collection methods have been described previously [19-21]. The inclusion criteria consisted of patients with a diagnosis of T1D by a physician.…”

Section: Methodsmentioning

confidence: 99%

Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil

Gomes¹,

Negrato²,

Cobas³

et al. 2014

Diabetol Metab Syndr

View full text Add to dashboard Cite

BackgroundTo evaluate the determinants of intensive insulin regimens (ITs) in patients with type 1 diabetes (T1D).MethodsThis multicenter study was conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. Data were obtained from 3,591 patients (56.0% female, 57.1% Caucasian). Insulin regimens were classified as follows: group 1, conventional therapy (CT) (intermediate human insulin, one to two injections daily); group 2 (three or more insulin injections of intermediate plus regular human insulin); group 3 (three or more insulin injections of intermediate human insulin plus short-acting insulin analogues); group 4, basal-bolus (one or two insulin injections of long-acting plus short-acting insulin analogues or regular insulin); and group 5, basal-bolus with continuous subcutaneous insulin infusion (CSII). Groups 2 to 5 were considered IT groups.ResultsWe obtained complete data from 2,961 patients. Combined intermediate plus regular human insulin was the most used therapeutic regimen. CSII was used by 37 (1.2%) patients and IT by 2,669 (90.2%) patients. More patients on IT performed self-monitoring of blood glucose and were treated at the tertiary care level compared to CT patients (p < 0.001). The majority of patients from all groups had HbA1c levels above the target. Overweight or obesity was not associated with insulin regimen. Logistic regression analysis showed that economic status, age, ethnicity, and level of care were associated with IT (p < 0.001).ConclusionsGiven the prevalence of intensive treatment for T1D in Brazil, more effective therapeutic strategies are needed for long term-health benefits.

show abstract

Determinants of self‐monitoring of blood glucose in patients with Type 1 diabetes: a multi‐centre study in Brazil

Cited by 17 publications

References 26 publications

Financial costs for families of children with Type 1 diabetes in lower‐income countries

Financial costs for families of children with Type 1 diabetes in lower‐income countries

Inequalities in glycaemic control, hypoglycaemia and diabetic ketoacidosis according to socio‐economic status and area‐level deprivation in Type 1 diabetes mellitus: a systematic review

Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil

Contact Info

Product

Resources

About